Abstract
From a strictly therapeutic point of view, bone marrow failure resulting from irradiation presents three main challenges to the clinician: (1) to correct any metabolic disturbances, either of the hydroelectrolytic compartment or of a nutritional nature; (2) to compensate for cytopenias, particularly of granulocytes and platelets; and (3) to prevent or treat infections. These goals can be achieved only through supportive, substitutive, or compensative therapies. In this chapter, I summarize the principal therapies that have been adopted for preventing and treating the infectious complications of the hematopoietic syndrome—complications that derive basically from transient granulocytopenia, which usually lasts for about 2 weeks. Severe bone marrow failure appears when significant body volumes receive doses of about 4-6 Gy within a short period of time. The clinician must bear in mind that the hematopoietic syndrome can put the life of an irradiated person at risk. Patients with severe granulocytopenia (less than 100/pL) tend to develop early and possibly fatal infectious fevers. Despite the possibility that a concomitant hemorrhage might occur, which certainly would contribute to an increase in the mortality rate, it has seldom been observed in accidentally irradiated persons. Infectious complications are responsible for most fatalities. The basic rules adopted for preventing and treating infectious complications observed in accidentally irradiated persons do not differ substantially from those used for treating cancer patients who present granulocytopenia as a consequence of either the underlying disease or their chemotherapy or radiotherapy regimens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schimpff, S. C., Satterlee, W., Young, V. M., et al. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Eng J Med 284: 1061–1065, 1971.
Hubner, K. F., and Fry, S. A., Eds. The Medical Basis for Radiation Accident Preparedness. Elsevier North Holland, Inc., New York, 1980.
Rubin, M., Hathorn, J. W., and Pizzo, P. A. Controversies in the management of febrile neutropenic cancer patients. Cancer Invest 6 (2): 167–184, 1988.
Pizzo, P. A., Hathorn, J. W., Hiemenz, J., et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Eng J Med 315 (9): 552–558, 1986.
Dejace, P., and Klastersky, J. Comparative review of combination therapy: Two beta-lactams versus beta-lactam plus aminoglycoside. Am J Med 80 (6B): 29–38, 1986.
Wade, J. C., Standiford, H. C., Drusano, G. L., et al. Potential of imipenem as a single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer. Am J Med 78 (5A): 62–72, 1985.
Karp, J. E., Merz, W. G., Hendricksen, C., et al. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. Ann Intern Med 106: 1–7, 1987.
Rubin, M., Hathorn, J. W., Marshall, D., et al. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 108: 30–35, 1988.
Wong, K. K., and Hirsch, M. S. Herpes virus infections in patients with neoplastic diseases. Diagnosis and therapy. Am J Med 76: 464–478, 1984.
Winston, D. J., Ho, W. G., and Gale, R. P. Therapeutic granulocyte transfusions for documented infections. Ann Intern Med 97: 509–515, 1982.
Butturini, A., DeSouza, P. C., Gale, R. P., et al. Use of recombinant granulocyte-macrophage colony-stimulating factor in the Brazil radiation accident. Lancet 11: 471–475, 1988.
Grabstein, K. H., Urdal, D. L., Tushiaski, R. J., et al. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 232: 506–508, 1986.
Weisbart, R. H., Golde, D. W., Clark, S. C., et al. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 314: 361–363, 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Oliveira, A.B. (1990). Treatment of Infectious Complications of the Hematopoietic Syndrome. In: Browne, D., Weiss, J.F., MacVittie, T.J., Pillai, M.V. (eds) Treatment of Radiation Injuries. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0864-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0864-3_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0866-7
Online ISBN: 978-1-4899-0864-3
eBook Packages: Springer Book Archive